In Numbers. Follow the progression of Covid-19 vaccinations in Tunisia

After nearly a month's delay, the vaccination campaign against Covid-19 in Tunisia finally began on March 13. The number of people vaccinated, the number of vaccine doses announced and received - will the government's objectives be met? View the regularly updated progress and projections of the campaign, in numbers.
Written by | 21 June 2021 | 10 minutes | Available in ArabicFrench
scroll to icon
51089
loader

Loading data from the server ...

What is the status of the Tunisian vaccination campaign?

Last updated on

Number of people registered
with E-vax

Number of people who have received
at least a single vaccine dose

 |    info box

Percentage of people who have received at least one vaccine dose, compared to the number of people registered with E-vax

Number of people who
are fully vaccinated

 |    info box

Percentage of the population who are fully vaccinated

Number of people fully
vaccinated (two doses)

Number of people fully
vaccinated (single dose + Covid19)

Number of vaccine doses received

Of which 100,000 doses are reserved for personnel at the Ministry of Defence,
the Ministry of the Interior and Customs.

Number of vaccine
doses administered

 |    info box

Percentage of doses administered compared to the number of doses received

Progression of doses administered

So far, Tunisia has only procured two-dose vaccines. A marketing authorisation (MA) was recently granted for the American vaccine Johnson & Johnson, which only requires a single dose. The latter has not yet been distributed in the country.

By
As of March 25, the cumulated number of vaccinations declared by the Ministry of Health no longer corresponds to the cumulated number calculated by Inkyfada, based on the declared number of administered daily doses. The dotted line shows the figures calculated by Inkyfada.

Government objective: 50% of the population to be fully vaccinated by December 2021

To vaccinate 50% of the population, 5,909,309 people need to be fully vaccinated. This means either having received two vaccine doses, or having received a single dose as well as having been previously infected with Covid-19. This is due to the fact that people who have contracted the virus only need one dose of the vaccine in order to develop antibodies.

30 Juin 2021

Government objective of 3 million people vaccinated

date vacination icon Objective not met

Merely 643 457 people were fully vaccinated by this date.

date vacination icon 31 December 2021

objectif juin

date vacination icon

Number of people who would need to be fully vaccinated per day to meet this deadline

date vacination icon

Daily average of the last 7 days

Projection based on the objectives set by the government

To vaccinate 50% of the population, 5,909,309 people need to be fully vaccinated. This means either having received two vaccine doses, or having received a single dose as well as having been previously infected with Covid-19. This is due to the fact that people who have contracted the virus only need one dose of the vaccine in order to develop antibodies.

date vacination icon

Date by which the government's objective (5,909,309 fully vaccinated people) will have been met at the current rate

210 d

Estimated delay in meeting the government's objective

date vacination icon

Daily average of the last 7 days

The vaccines to be distributed in Tunisia

Last updated on

Click on the icon for further details

WHO: World Health Organisation - WMA: Marketing Authorisation

Pfizer

German-American vaccine - Efficiency rate: 95%

WHO
Approval

Obtained

MA
of Tunisia

31/12/2020

Arrival
of the first doses

31/12/2020

Number of doses administered

193 600

Number of doses received

93 600
show-more

Pfizer's vaccine is a messenger RNA vaccine, which involves injecting the genetic material of the virus into human cells. The immune system then recognises the material as foreign and produces effective antibodies against the virus.It was the first vaccine to be approved by the World Health Organisation (WHO). Tunisia granted it marketing authorisation (WMA) in January 2021, but the first doses only arrived in mid-March via COVAX (a WHO initiative), as well as through direct purchase from Pfizer.

AstraZeneca/Oxford

Swedish-British vaccine - Efficiency rate: 70%

WHO
Approval

15/02/2021

MA
of Tunisia

26/02/2021

Arrival
of the first doses

26/02/2021

Number of doses administered

397 000

Number of doses received

0
show-more

Like Sputnik V, the AstraZeneca/Oxford's vaccine is a viral vector vaccine. After several cases of serious side effects among relatively young people, many countries, such as France and Belgium, have decided to administer the vaccine only to those over 55 years of age. Tunisia received the first doses of this vaccine in early April 2021. The scientific council subsequently recommended that it be used only for people over 60 years of age.

Sputnik V

Russian vaccine - Efficiency rate: 91,6%

WHO
Approval

30/01/2021

MA
of Tunisia

30/01/2021

Arrival
of the first doses

09/03/2021

Number of doses administered

530 000

Number of doses received

30 000
show-more

The Sputnik V vaccine is a viral vector vaccine. As with the messenger RNA vaccine, it is based on the genetic material of the virus, the only difference being that it is injected into human cells via a harmless virus. The virus then replicates and spreads, triggering the body's immune response. The 30,000 doses received at the beginning of March enabled Tunisia to commence its vaccination campaign. The Russian vaccine was therefore the first to arrive and be distributed on Tunisian soil.

CoronaVac

Chinese Vaccine - Efficiency rate: 50,38%

WHO
Approval

04/03/2021

MA
of Tunisia

04/03/2021

Arrival
of the first doses

Pending

Number of doses administered

193 600

Number of doses received

93 600
show-more

The CoronaVac vaccine from the Chinese company Sinovac is an inactivated virus vaccine. As the most conventional method, it involves injecting a chemically inactivated form of the virus into the cells. The human body then identifies the virus and produces antibodies to neutralise it. The overall efficiency rate of CoronaVac is 50.38% following the second dose, which is one of the lowest rates among the vaccines obtained by Tunisia. Tunisia obtained the vaccine as a donation from China. After Sputnik V, CoronaVac was the second vaccine to be administered throughout the country.

Johnson & Johnson

American vaccine - Efficiency rate: 66%

WHO
Approval

08/04/2021

MA
of Tunisia

08/04/2021

Arrival
of the first doses

Pending

Number of doses administered

--

Number of doses received

--
show-more

Like Sputnik V and AstraZeneca/Oxford, the Johnson & Johnson vaccine is also a viral vector vaccine. What separates it from the other two vaccines is that it only requires one dose instead of two. There have been reports of serious side effects in the US. However, the European Medicines Agency decided to still distribute the vaccine in Europe as these side effects are considered to be very rare. As the latest vaccine to receive marketing authorisation from Tunisia, it should be delivered through COVAX and CDC Africa.

What is the global vaccination status?

Last updated on

The portion of the population that has received at least a single vaccine dose. To be fully vaccinated, a person typically needs to have received two doses.

Source: Official data collected by ‘Our World in Data’ and Inkyfada.

World

Maghreb

Africa

0% 1% 5% 10% 20% 30% 40% 50% 60% 70% 100%

Which countries are vaccinating the most?

World

Maghreb

Africa